What are the AANS/CNS guidelines on the initial treatment of acute spinal cord injury (SCI)?

Updated: Nov 01, 2018
  • Author: Lawrence S Chin, MD, FACS; Chief Editor: Brian H Kopell, MD  more...
  • Print
Answer

Administration of methylprednisolone (MP) for the treatment of acute spinal cord injury (SCI) is not recommended. Clinicians considering MP therapy should bear in mind that the drug is not Food and Drug Administration (FDA) approved for this application. 

Administration of GM-1 ganglioside (Sygen) for the treatment of acute SCI is not recommended.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!